FOX vs NKTR · P/E 13, $24.49B cap vs rev $21.0M
Fox Corp Class B (FOX) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
FOX does not have a complete income-statement cache yet.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the FOX and NKTR stock pages for the full models.
Not investment advice.